BTS
WX

BB&T Securities’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BB&T Securities’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,124
Closed -$398K – 1083
2014
Q2 		$398K Sell
12,124
-11,454
-49% -$392K 0.01% 716
2014
Q1 		$869K Buy
23,578
+1,039
+5% +$38.1K 0.02% 451
2013
Q4 		$865K Buy
+22,539
New +$712K 0.02% 417

Other funds holding WX

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BB&T Securities's WX Position: Q3 2014 in Review

BB&T Securities sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2014, closing a stake of 12,124 shares — an estimated $398K sold.

BB&T Securities first reported a position in WX in Q4 2013 and held it in 3 quarters. The position peaked at $869K in Q1 2014. 157 funds tracked by Wall St. Rank hold WX as of Q3 2014.

  • BB&T Securities reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2014 after selling out during the quarter.
  • BB&T Securities sold 12,124 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2014, an estimated $398K.
  • BB&T Securities first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 3 quarters.
  • BB&T Securities's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $869K in Q1 2014.
  • 157 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2014.

Based on BB&T Securities's 13F filing for Q3 2014, filed 21 Oct 2014.